Cargando…
Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies
Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL). Yet, prolonged GC use is hampered by deleterious GC-related side effects and the emergence of GC resistance. To tackle and overcome these GC-related...
Autores principales: | Clarisse, Dorien, Van Wesemael, Karlien, Tavernier, Jan, Offner, Fritz, Beck, Ilse M., De Bosscher, Karolien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940183/ https://www.ncbi.nlm.nih.gov/pubmed/29738549 http://dx.doi.org/10.1371/journal.pone.0197000 |
Ejemplares similares
-
Coregulator profiling of the glucocorticoid receptor in lymphoid malignancies
por: Clarisse, Dorien, et al.
Publicado: (2017) -
Crosstalk between glucocorticoid and mineralocorticoid receptors boosts glucocorticoid-induced killing of multiple myeloma cells
por: Clarisse, Dorien, et al.
Publicado: (2023) -
How the glucocorticoid receptor contributes to platinum-based therapy resistance in solid cancer
por: Clarisse, Dorien, et al.
Publicado: (2021) -
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments
por: Sundahl, Nora, et al.
Publicado: (2016) -
Compound A, a Selective Glucocorticoid Receptor Modulator, Enhances Heat Shock Protein Hsp70 Gene Promoter Activation
por: Beck, Ilse M., et al.
Publicado: (2013)